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Abstract Asparaginyl endopeptidases, or legumains, are a
recently identified family of cysteine-class endopeptidases. A
single gene encoding a Schistosoma mansoni asparaginyl
endopeptidase (a.k.a. Sm32 or schistosome legumain) has been
reported, but by sequence homology it would be expected to yield
an inactive product as the active site C197 had been replaced by
N. We now describe a new S. mansoni gene in which C197 is
present. Both gene products were expressed in Pichia pastoris.
Autocatalytic processing to fully active C197 Sm32 occurred at
acid pH. In contrast, N197 Sm32 was not processed and this is
consistent with the hypothesis that C197 is essential for catalysis.
This was confirmed by mutation of N197 to C and re-expression
in Pichia. The availability of recombinant active Sm32 allows
detailed analysis of its catalytic mechanism and its function(s) in
the biology of this important human parasite.
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1. Introduction
Asparaginyl endopeptidases or legumains are a novel family
of cysteine-class endopeptidases with members reported in
plants [1], mammals [2] and in the parasitic blood £uke Schis-
tosoma spp. [3]. Asparaginyl endopeptidases are proposed to
belong to the CD clan of cysteine endopeptidases along with
caspases, clostripain and gingipains [4]. They have a speci¢city
for an asparaginyl residue in the P1 position of the substrate
(terminology of Schechter and Berger [5]) for hydrolysis and
possess an approximately 15 kDa extension C-terminal of the
catalytic domain [1^3]. In plants, legumains process seed pre-
cursor proteins to their ¢nal forms [6,7]. In mammals, the
related asparaginyl endopeptidases have a key function in
the initial processing of antigens for MHC class II presenta-
tion [8] and in the inhibition of osteoclast formation and bone
resorption [9].
The asparaginyl endopeptidase of S. mansoni (a.k.a. Sm32)
is an important immunodiagnostic antigen for schistosomiasis
[10]. A single Sm32 gene in both the S. mansoni and S. japo-
nicum species has been identi¢ed [3,11,12]. However, on the
basis of sequence homology with other asparaginyl endopep-
tidases, the product of this Sm32 gene would not be proteo-
lytically active as the crucial active site cysteine residue at
position 197 had been replaced by an asparagine (N197
Sm32) [4]. We now identify a second distinct gene for Sm32
containing the requisite C197 residue (C197 Sm32). Using the
Pichia pastoris protein expression system, we have expressed
recombinant, active C197 Sm32. We further show by site-di-
rected mutagenesis (N197C) that N197 Sm32 is rendered pro-
teolytically active and demonstrate that autocatalysis at acid
pH leads to production of mature, active Sm32, accompanied
by removal of the C-terminal extension and possibly of the N-
terminal pro-domain.
2. Materials and methods
2.1. Cloning and sequencing of C197 Sm32, and site-directed
mutagenesis
Poly(A) mRNA was isolated (Pharmacia) from 6-week-old S.
mansoni worms of mixed sex and converted to single-stranded
cDNA using AMV Reverse Transcriptase as described by the manu-
facturer (Life Technologies). PCR ampli¢cation of the C197 Sm32
gene was accomplished with primers designed to encompass the pro-
and C-terminal regions of the endopeptidase: forward: 5P-ATACTC-
GAGAAAAGACAATTAGATACAAATTATGAAGTATCC-3P and
reverse: 5P-AATGCGGCCGCTTAACCGCAAATTTTTATGATT-
GCT-3P. For eventual cloning into the P. pastoris expression vector
pPIC ZK A, the forward primer incorporated XhoI endonuclease and
Kex 2 endopeptidase sites (both underlined) immediately 5P of the
gene-speci¢c sequence. The reverse primer incorporated a transcrip-
tion termination codon and a NotI site (both underlined) immediately
3P of the gene-speci¢c sequence. Ampli¢cation reactions were per-
formed with Pwo polymerase (Boehringer) with 35 cycles of 94‡C,
55‡C and 72‡C, each for 1 min. PCR products were puri¢ed (Qiagen)
and digested with XhoI and NotI. pPIC ZK A was similarly digested
and ligated to the PCR products. For sequencing, the same PCR
products were ampli¢ed using the above PCR conditions and cloned
into pCR-Blunt II-TOPO according to the manufacturer’s (Invitro-
gen) instructions. A unique A£III restriction site was found for C197
Sm32 (see below) and was used to distinguish such clones from those of
N197 Sm32. The signal peptide sequence of C197 Sm32 was obtained
from individual Blunt II-TOPO clones that had been generated using a
forward primer directed to the signal peptide (5P-ATGATGCTA-
TTCTCTTTATTTCTTA-3P) and the above-described reverse primer.
PCR conditions to generate such clones were as described above. The
entire open reading frame (ORF) of C197 Sm32 was sequenced in
both directions. To generate the N197C mutant Sm32, site-directed
mutagenesis was performed by sequential PCR steps [13] using the
forward primer 5P-TTATATTGAAGCATGTGAATCAGG-3P (bases
encoding the mutation are underlined) and the appropriate anti-par-
allel reverse primer. This mutation resulted in the same A£III site as
found in C197 Sm32. All recombinant plasmids were propagated in
DH5K cells (Life Technologies) and puri¢ed (Qiagen).
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2.2. Expression of Sm32 in P. pastoris
Procedures to express Sm32 in the X33 strain of P. pastoris were as
detailed by the manufacturer (Invitrogen). Brie£y, recombinant pPIC
ZK A (10 Wg) was linearized with SacI and puri¢ed. P. pastoris was
electroporated at 1.5 kV and 129 6 in electroporation cuvettes (2 mm
gap; BTX). Pichia colonies growing under zeocin (Invitrogen) selec-
tion were picked for expansion ¢rst in 10 ml of yeast extract^peptone^
dextrose medium containing 100 Wg/ml zeocin and then in 200^400 ml
of the same medium. Expression of recombinant protein was induced
by incubation of Pichia for 48 h in bu¡ered-minimal medium contain-
ing 1% methanol as the sole carbon source. Culture medium was
clari¢ed through a 0.45 Wm ¢lter, lyophilized and stored at 4‡C.
Lyophilized culture media containing recombinant Sm32 were resus-
pended in 0.1 M citrate^phosphate, pH 6.8 to a volume one-tenth of
Fig. 1. Nucleotide and deduced amino acid sequence of C197 Sm32. Active site histidine and cysteine residues are presented in bold; potential
glycosylation sites are underlined and arrows [14] indicate the putative N-termini of the pro-domain, mature protease and C-terminal extension.
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that of the original. Complete bu¡er exchange was accomplished us-
ing PD10 desalting columns (Pharmacia). Solutions were concentrated
10 times in Centricon 10 centrifugation units (Millipore) and stored at
320‡C.
2.3. Detection and activation of recombinant Sm32, and endopeptidase
assays
Recombinant Sm32 was detected by immunoblotting after SDS^
PAGE (4^12% gradient gels; Novex) using a monospeci¢c rabbit
antiserum developed to recombinant N197 Sm32 expressed in Escher-
ichia coli (Ewald Beck, Biochemisches Institut, Universita«t Giessen,
Germany). For activation experiments, enzyme solution was incu-
bated for di¡erent time periods at 37‡C in the presence of 2 mM
dithiothreitol (DTT) and no further additions (pH was measured to
be 6.8) or 0.2 M sodium acetate pH 4.5 (pH was adjusted using a one-
tenth volume of 2 M sodium acetate pH 4.5). The following endopep-
tidase inhibitors (¢nal concentrations were 14 WM unless otherwise
indicated) were tested for their ability to prevent activation of
Sm32: iodoacetic acid (IA; 5 WM), E-64, morpholinourea-Phe-homo-
Phe-vinyl sulfone phenyl, PMSF (2 mM) leupeptin, pepstatin A and
1,10-phenanthroline (2 mM). Endopeptidase activity was monitored
by hydrolysis of benzyloxy (Z)-Ala-Ser-Asn-7-amido-4-methylcou-
marin (NMec; custom synthesis, Enzyme Systems Products). In our
hands, this substrate is degraded by Sm32 approximately twice as fast
as the more commonly used Z-Ala-Ala-Asn-NMec (Ca¡rey, unpub-
lished observation). Assays were performed in black 96-well microtiter
plates and contained 5^30 Wl enzyme solution preincubated for 10 min
in 100 Wl 0.1 M citrate^phosphate, 2 mM DTT, pH 6.8. Substrate
(stocks in dimethyl sulfoxide) in 100 Wl of the same bu¡er (10 WM)
was then added and the reaction allowed to proceed for 20^30 min at
room temperature. Fluorescence was measured in a Labsystems Flu-
oroskan II plate reader at excitation and emission wavelengths of 355
and 460 nm, respectively.
3. Results and discussion
3.1. A second gene encodes Sm32 with cysteine in the active site
Heretofore, only one complete gene sequence has been iden-
ti¢ed for Sm32 (a.k.a. S. mansoni asparaginyl endopeptidase
or schistosome legumain) [3,11]. This was predicted to encode
an inactive enzyme as the active site C197 had been replaced
by an asparagine residue [4]. Consistent with this prediction,
our preliminary attempts to obtain endopeptidase activity
from an N197 clone expressed in P. pastoris had failed. Sub-
sequent isolation and sequencing of a number of clones de-
rived from S. mansoni mRNA identi¢ed a second gene for
Sm32 where C197 was present and the entire ORF is pre-
sented in Fig. 1. C197 Sm32 has 97.2 and 41.0% identity to
the previously published N197 Sm32 [11] and human legu-
main [2], respectively (Fig. 2). C197 Sm32 di¡ers from N197
Sm32 by 12 amino acid residues. Also, C197 Sm32 has two
potential N-glycosylation sites whereas N197 Sm32 has three,
one of which, interestingly, is found at position 197.
3.2. Expression of Sm32 forms in P. pastoris and activation of
C197 Sm32
Both N197 and C197 Sm32 were expressed and detectable
Fig. 2. Amino acid sequence alignment of C197 Sm32 with N197 Sm32 [11] and human legumain [2]. Amino acid residues di¡ering between
the two schistosome sequences are indicated by asterisks; areas where all three sequences are identical are shaded.
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in Pichia cultures using an anti-N197 Sm32 monospeci¢c rab-
bit serum (Fig. 3). In fresh preparations of the N197 Sm32, a
single immunoreactive protein was detected at 50 kDa (Fig.
3a). For C197 Sm32, predominant protein bands at 50 and 47
kDa were detected with minor species at 42 and 39 (Fig. 3b).
Very little hydrolysis (6 5%) of the £uorogenic substrate Z-
Ala-Ser-Asn-NMec could be detected in fresh C197 Sm32
preparations (Fig. 4). Signi¢cant endopeptidolytic activity
was only evident on incubation of C197 Sm32 preparations
at pH 4.5 and correlated with the appearance of a ¢nal pro-
tein product at 34 kDa (Fig. 3b, 2 h time point onwards).
Prolonged incubation of C197 Sm32 at pH 6.8 did not evince
increased hydrolysis of the £uorogenic substrate from the 5%
basal level (Fig. 4) nor conversion of the major 50 and 47 kDa
proteins (not shown), thus indicating the acid pH requirement
for conversion to the fully active enzymatic form. In contrast
to C197 Sm32, N197 Sm32 was incapable of being activated,
either at pH 4.5 (Fig. 3) or at pH 6.0 (not shown), and did not
hydrolyze Z-Ala-Ser-Asn-NMec (Fig. 4). These results sup-
port the prediction based on sequence homology [4] that
Sm32 with N rather than C at position 197 would be most
likely inactive.
3.3. Activation of Sm32 requires Cys at position 197 and is an
autocatalytic event
Con¢rmation that the endopeptidolytic activity of Sm32
requires Cys at position 197 was obtained by recombinant
expression of N197 Sm32 where the active site Asn at 197
had been mutated to a Cys. Like C197 Sm32, the N197C
mutant was capable of being activated, but only at pH 4.5
(Figs. 4 and 5) and not at pH 6.8 (not shown). Also, increased
hydrolysis of Z-Ala-Ser-Asn-NMec was only associated with
the appearance of the ¢nal protein product which resolved at
37 kDa (Fig. 5, 2 h time point and onwards). Tests with
endopeptidase inhibitors formally eliminate the possibility
that an endopeptidase(s) other than Sm32 in the Pichia cul-
ture medium activates Sm32 in trans. Only the general cys-
teine endopeptidase inhibitor IA blocked activation of both
C197 (Fig. 3b) and N197C mutant Sm32 (Fig. 5). Impor-
tantly, inhibitors of papain-like cysteine endopeptidases such
as E-64, morpholino-Phe-homoPhe-vinyl sulfone phenyl (Fig.
3b) and leupeptin (not shown) did not prevent conversion to
the ¢nal enzyme forms. E-64 has previously been shown to be
relatively ine¡ective against asparaginyl endopeptidase activ-
ity in schistosome extracts [15] and pig legumain [2]. Likewise,
inhibitors of serine (PMSF and leupeptin), aspartic (pepstatin
A) and metallo-endopeptidases (1,10-phenanthroline) were in-
e¡ective (not shown).
3.4. The function of the C-terminal extension in Sm32
The immunoblot and enzymatic experiments herein demon-
strate that maximal endopeptidolytic activity of C197 and
N197C mutant Sm32 is associated with the autocatalytic pro-
cessing of an approximately 50 kDa protein species to about
35 kDa. Consistent with plant and animal legumains [1^3], loss
of the C-terminal extension and possibly of the N-terminal
pro-domain would account for this conversion. Given the
speci¢city of asparaginyl endopeptidases like Sm32 for Asn
at P1, the processing sites for removal of the N-terminal
pro-domain and the C-terminal extension of Sm32 as previ-
ously proposed [14] (Fig. 1) must now be re-evaluated. The
identi¢cation of a 50 kDa Sm32 precursor and a 35 kDa
mature protein agrees with the detection of native asparaginyl
endopeptidase species in S. mansoni extracts [16]. It is not
clear, however, whether the conversion to the fully active en-
Fig. 3. Conversion of C197, but not N197 Sm32, to the ¢nal active
enzyme product. As described in Section 2, Sm32 proteins, ex-
pressed in P. pastoris supernatants, were incubated at 37‡C in the
presence of DTT at pH 4.5 for di¡erent time periods. After SDS^
PAGE and blotting onto PVDF membrane, supernatants were re-
acted with a monospeci¢c anti-N197 Sm32 rabbit serum. a: N197
Sm32 after incubation at pH 4.5 for 0 and 15 h. b: as for a, but
with C197 Sm32; inhibitors were incubated for 15 h with C197
Sm32. IA, iodoacetic acid; F-hF, morpholinourea-Phe-homoPhe-vi-
nyl sulfone phenyl.
Fig. 4. Conversion to ¢nal Sm32 products at acid pH is associated
with increased endopeptidolytic activity. As described for the above
experiments (Section 2 and Fig. 3) N197, C197 or N197C mutant
Sm32 was incubated at pH 6.8 or 4.5 for di¡erent time periods for
up to 15 h. Endopeptidolytic activity of various Sm32 preparations
was measured using the £uorogenic substrate Z-Ala-Ser-Asn-NMec.
Incubation at pH 4.5; N197 (O), C197 (b) and N197C mutant (F).
Incubation at pH 6.8; C197 (a) and N197C mutant (E).
Fig. 5. Mutating N197 to C restores the ability of N197 Sm32 to
convert to the ¢nal active Sm32 product. Experimental design was
as for C197 Sm32 (legend to Fig. 3 and Section 2). IA, iodoacetic
acid.
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zyme in the worm is a cis or trans event. The C-terminal
extension may perform a function similar to that of the N-
terminal pro-region of papain-like endopeptidases such as
cathepsin B and L [17] by inhibiting the active site until ac-
tivity is required by the cell.
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